Pharmaco - Press Releases

Date	Title	Company
15-Jan-2020	Hoth Therapeutics Exercises Patent Licensing Option with the George Washington University to Further Develop a Therapeutic for Cancer Patients Suffering Cutaneous Changes Like Rash and Hair Loss, as Well as Other Neurogenic Inflammation Side Effects	Hoth Therapeutics, Inc.
15-Jan-2020	4SC AG: First Patient Enrolled in DONIMI Study Evaluating Domatinostat in the Neoadjuvant Setting in Melanoma	4SC AG
15-Jan-2020	Biotest AG: Biotest's CMV-specific hyperimmunoglobulin Cytotect CP Biotest receives UK marketing authorisation	Biotest AG
15-Jan-2020	Nektar Issues Statement Regarding FDA Advisory Committee Vote for Oxycodegol	Nektar Therapeutics
14-Jan-2020	Cardax, Inc. Announces Reverse Stock Split of Common Stock	Cardax, Inc.
14-Jan-2020	Phio Pharmaceuticals Announces Reverse Stock Split	Phio Pharmaceuticals Corp.
14-Jan-2020	Foamix Announces AMZEEQ(TM) (minocycline) Achievement of Preferred Status on Express Scripts National Preferred Formulary, One of the Largest Commercial Formularies in the U.S.	Foamix Pharmaceuticals Ltd.
14-Jan-2020	CNS Pharmaceuticals Announces Contract with International GMP Manufacturer for Production of Berubicin	CNS Pharmaceuticals, Inc.
14-Jan-2020	ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule	B3C newswire
14-Jan-2020	B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG publishes annual report for financial year 2018/19	B.R.A.I.N. Biotechnology Research And Information Network AG
14-Jan-2020	JUST - EVOTEC BIOLOGICS ENTERS INTO MULTI-YEAR COLLABORATION WITH MSD AROUND FACILITY OF THE FUTURE	Evotec SE
14-Jan-2020	JUST - EVOTEC BIOLOGICS INITIATES CONSTRUCTION OF FIRST J.POD(R) FACILITY IN NORTH AMERICA	Evotec SE
14-Jan-2020	Vivoryon Therapeutics AG: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration	Vivoryon Therapeutics AG
14-Jan-2020	Biofrontera AG: Biofrontera announces 1-year follow-up results for its phase III study of photodynamic therapy for actinic keratosis on the extremities and trunk/neck	Biofrontera AG
14-Jan-2020	Innovent Out-Licenses Commercial Rights for Avastin® Biosimilar to Coherus BioSciences in the United States and Canada	Innovent Biologics, Inc.
14-Jan-2020	Genome & Company announces a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer	Genome & Company
14-Jan-2020	Innovent Out-Licenses Commercial Rights for Avastin® Biosimilar to Coherus BioSciences in the United States and Canada	Innovent Biologics, Inc.
14-Jan-2020	Genome & Company announces a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer	Genome & Company
13-Jan-2020	Vanda Pharmaceuticals Wins Key U.S. Supreme Court Patent Ruling on Fanapt®	Vanda Pharmaceuticals Inc.
13-Jan-2020	Hansa Biopharma provides business update ahead of the JP Morgan Global Healthcare Conference	Hansa Biopharma